23IKIGAI Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
85
- Latest Deal Type
-
Later Stage VC
- (Cancelled)
- Latest Deal Amount
-
$200M
- Investors
-
16
23IKIGAI General Information
Description
Developer of advanced gene therapeutics intended for the treatment and prevention of medical conditions like cancer and diseases of aging. The company makes molecular medicines and nutrigenomic formulations and has co-developed, along with being the sole licensee of cancer prognostic and diagnostic technology, providing medical professionals with tools to diagnose and treat cancer and diseases related to aging.
Contact Information
Website
tzarlabs.ukCorporate Office
- 101, 1st Floor, Todi Building, Mathuradas Mills Compound
- Senapati Bapat Marg, Lower Parel West
- Mumbai, Maharashtra 400013
- India
Corporate Office
- 101, 1st Floor, Todi Building, Mathuradas Mills Compound
- Senapati Bapat Marg, Lower Parel West
- Mumbai, Maharashtra 400013
- India
23IKIGAI Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 10-Sep-2024 | $200M | Cancelled | Generating Revenue | ||
| 3. Later Stage VC (Series B) | 03-Oct-2024 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 04-Jun-2018 | $1.77M | $2.65M | Completed | Product In Beta Test | |
| 1. Angel (individual) | 25-Feb-2016 | $881K | $881K | Completed | Product In Beta Test |
23IKIGAI Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 1,506 | $0.119325 | $475.39 | $475.39 | 1x | $475.39 | 5.88% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
23IKIGAI Signals
23IKIGAI Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Dominor | Venture Capital | Minority | ||
| East River Advisors | Other | Minority | ||
| JITO Incubation & Innovation Foundation | Accelerator/Incubator | Minority |
23IKIGAI FAQs
-
When was 23IKIGAI founded?
23IKIGAI was founded in 2012.
-
Where is 23IKIGAI headquartered?
23IKIGAI is headquartered in Mumbai, India.
-
What is the size of 23IKIGAI?
23IKIGAI has 85 total employees.
-
What industry is 23IKIGAI in?
23IKIGAI’s primary industry is Drug Discovery.
-
Is 23IKIGAI a private or public company?
23IKIGAI is a Private company.
-
What is 23IKIGAI’s current revenue?
The current revenue for 23IKIGAI is .
-
How much funding has 23IKIGAI raised over time?
23IKIGAI has raised $10.1M.
-
Who are 23IKIGAI’s investors?
, , Dominor, East River Advisors, and JITO Incubation & Innovation Foundation are 5 of 16 investors who have invested in 23IKIGAI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process